Federated Hermes, Inc. Alector, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Alector, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 33,436 shares of ALEC stock, worth $63,194. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,436

Previous 68,538 51.22%

Holding current value

$63,194

Previous $311,000 49.84%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$4.34 - $6.58 $152,342 - $230,971	-35,102 Reduced 51.22%	33,436 $156,000
Q2 2024 Aug 08, 2024	BUY	$4.19 - $6.23 $11,350 - $16,877	2,709 Added 4.12%	68,538 $311,000
Q1 2024 May 14, 2024	BUY	$5.69 - $8.08 $7,431 - $10,552	1,306 Added 2.02%	65,829 $396,000
Q4 2023 Jan 31, 2024	SELL	$3.77 - $8.39 $343,571 - $764,605	-91,133 Reduced 58.55%	64,523 $514,000
Q3 2023 Nov 13, 2023	SELL	$5.2 - $8.77 $1.73 Million - $2.91 Million	-332,078 Reduced 68.09%	155,656 $1.01 Million
Q2 2023 Aug 14, 2023	SELL	$5.86 - $7.93 $13.2 Million - $17.9 Million	-2,260,419 Reduced 82.25%	487,734 $2.93 Million
Q1 2023 May 08, 2023	SELL	$5.85 - $9.84 $10.7 Million - $17.9 Million	-1,823,507 Reduced 39.89%	2,748,153 $17 Million
Q4 2022 Feb 13, 2023	SELL	$6.88 - $9.55 $7.46 Million - $10.4 Million	-1,084,941 Reduced 19.18%	4,571,660 $42.2 Million
Q3 2022 Nov 14, 2022	SELL	$8.19 - $13.2 $738,975 - $1.19 Million	-90,229 Reduced 1.57%	5,656,601 $53.5 Million
Q2 2022 Aug 15, 2022	SELL	$7.65 - $14.24 $1.41 Million - $2.62 Million	-184,204 Reduced 3.11%	5,746,830 $58.4 Million
Q1 2022 May 13, 2022	BUY	$13.02 - $20.78 $8.47 Million - $13.5 Million	650,187 Added 12.31%	5,931,034 $84.5 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $5.42 Million - $7.15 Million	279,929 Added 5.6%	5,280,847 $109 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $9.94 Million - $18.1 Million	459,119 Added 10.11%	5,000,918 $114 Million
Q2 2021 Aug 16, 2021	SELL	$15.5 - $22.48 $1.55 Million - $2.25 Million	-100,000 Reduced 2.15%	4,541,799 $94.6 Million
Q1 2021 May 13, 2021	BUY	$14.84 - $22.23 $5.33 Million - $7.99 Million	359,236 Added 8.39%	4,641,799 $93.5 Million
Q4 2020 Feb 12, 2021	SELL	$9.4 - $16.7 $5.48 Million - $9.74 Million	-583,306 Reduced 11.99%	4,282,563 $64.8 Million
Q3 2020 Nov 12, 2020	BUY	$10.54 - $24.96 $6.31 Million - $14.9 Million	598,515 Added 14.03%	4,865,869 $51.3 Million
Q2 2020 Aug 13, 2020	SELL	$21.87 - $33.11 $3.55 Million - $5.38 Million	-162,343 Reduced 3.66%	4,267,354 $104 Million
Q1 2020 May 13, 2020	BUY	$16.25 - $35.28 $9.97 Million - $21.6 Million	613,397 Added 16.07%	4,429,697 $107 Million
Q4 2019 Feb 14, 2020	BUY	$14.17 - $20.3 $2.27 Million - $3.25 Million	160,000 Added 4.38%	3,816,300 $65.8 Million
Q3 2019 Nov 14, 2019	BUY	$14.42 - $22.2 $32.8 Million - $50.5 Million	2,274,462 Added 164.6%	3,656,300 $52.7 Million
Q2 2019 Aug 14, 2019	BUY	$16.26 - $26.42 $3.39 Million - $5.51 Million	208,500 Added 17.77%	1,381,838 $26.3 Million
Q1 2019 May 10, 2019	BUY	$15.97 - $22.5 $18.7 Million - $26.4 Million	1,173,338 New	1,173,338 $22 Million

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $156M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Alector, Inc. Transaction History